Richard E. Champlin
The University of Texas MD Anderson Cancer Center · 2,094 works · 77,280 citations · h-index 146
Top works
- Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
- Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
- Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
- Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
- Unique Forms of the abl Tyrosine Kinase Distinguish Ph 1 -Positive CML from Ph 1 -Positive ALL
- Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia
- Zygomycosis in a Tertiary‐Care Cancer Center in the Era of Aspergillus‐ Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases
- Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells
- Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.
- Antithymocyte Globulin Treatment in Patients with Aplastic Anemia
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
- Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
- Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
- Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
- Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- Influenza A virus infections among hospitalized adult bone marrow transplant recipients.
- Acute myelogenous leukemia: recent advances in therapy
- Treatment of Acute Myelogenous Leukemia